Vleuten, Netherlands

Jeroen Johannes Gerardus Geurtsen



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jeroen Johannes Gerardus Geurtsen

Introduction

Jeroen Johannes Gerardus Geurtsen is an accomplished inventor based in Vleuten, Netherlands. He has made significant contributions to the field of vaccine development, holding two patents that focus on innovative methods to enhance vaccine efficacy against gram-negative bacteria.

Latest Patents

One of Geurtsen's latest patents pertains to an improved vaccine that utilizes modified Lipopolysaccharide (LPS) molecules or obtainable LPS molecules derived from mutants of specific gram-negative bacteria. These innovations may also serve as adjuvants, enhancing the immune response. Another noteworthy patent introduced novel gram-negative polypeptides with lipid A 3-O-deacylase activity, which play a crucial role in modifying and detoxifying gram-negative LPS. This invention outlines applications for pharmaceutical and veterinary use, particularly in the formulation of whole-cell or acellular vaccines targeting pathogenic gram-negative bacteria.

Career Highlights

Throughout his career, Jeroen Geurtsen has been associated with reputable organizations, including the NVI (Nederlands Vaccininstituut) and the Dutch State, represented by the Minister of Health, Welfare, and Sport. His work at these institutions has positioned him at the forefront of vaccine research and development.

Collaborations

Geurtsen has collaborated with renowned scientists in the field, including Johannes Petrus Maria Tommassen and Peter André Van Der Ley. Their collective expertise has facilitated significant advancements in vaccine technology and research.

Conclusion

Jeroen Johannes Gerardus Geurtsen stands out as a pioneering inventor in the realm of vaccine innovation. His patents not only showcase his commitment to improving public health but also underline the importance of collaboration in advancing scientific discovery. His work continues to influence the future of vaccine development, addressing critical health challenges posed by gram-negative bacteria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…